, Rhabdomyosarcoma: new windows of opportunity, vol.10, pp.518-527, 2005.
Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma, J. Clin. Oncol, vol.26, pp.406-413, 2008. ,
The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols, Sarcoma, vol.5, pp.9-15, 2001. ,
Incidence of sarcoma histotypes and molecular subtypes in a prospective, PLoS One, vol.6, p.20294, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00799650
Optimal management strategies for rhabdomyosarcoma in children, Paediatr. Drugs, vol.9, pp.391-400, 2007. ,
The intergroup rhabdomyosarcoma study-I. A final report, Cancer, vol.61, pp.209-220, 1988. ,
The intergroup rhabdomyosarcoma study-II, Cancer, vol.71, pp.1904-1922, 1993. ,
The third intergroup rhabdomyosarcoma study, J. Clin. Oncol, vol.13, pp.610-630, 1995. ,
Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease, J. Clin. Oncol, vol.19, pp.3091-3102, 2001. ,
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89, J. Clin. Oncol, vol.23, pp.2618-2628, 2005. ,
Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution, Cancer, vol.98, pp.571-580, 2003. ,
Adult rhabdomyosarcoma: outcome following multimodality treatment, Cancer, vol.95, pp.377-388, 2002. ,
Clinicopathologic analysis of patients with adult rhabdomyosarcoma, Cancer, vol.91, pp.794-803, 2001. ,
Adult rhabdomyosarcoma survival improved with treatment on multimodality, Int. J. Radiat. Oncol. Biol. Phys, vol.86, pp.58-63, 2013. ,
Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients, Cancer Med, vol.2, pp.553-563, 2013. ,
Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma, Ann. Surg, vol.234, pp.215-223, 2001. ,
The effect of age at diagnosis on outcome in rhabdomyosarcoma, Cancer, vol.73, pp.109-117, 1994. ,
Improved survival using specialized multidisciplinary board in sarcoma patients, Ann. Oncol, vol.28, pp.2852-2859, 2017. ,
Embryonal rhabdomyosarcoma in adults, Cancer, vol.51, pp.557-565, 1983. ,
, , 2015.
, Rhabdomyosarcoma an Ambispective Study aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?, Eur. J. Cancer, vol.51, pp.193-201
LBA6_PR -Full-dose neoadjuvant anthracycline + ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized trial, 2016. ,
Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database, Ann. Oncol, vol.21, pp.2436-2441, 2010. ,
, Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration, Lancet, vol.350, pp.1647-1654, 1997.
A systematic metaanalysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma, Cancer, vol.113, pp.573-581, 2008. ,
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial, Lancet Oncol, vol.13, pp.1045-1054, 2012. ,
Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.21, pp.198-203, 2010. ,
Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven, Oncologist, vol.14, pp.1013-1020, 2009. ,
, Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.25, issue.3, pp.102-112, 2014.
Surgical principles for children/adolescents with newly diagnosed rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group, Sarcoma, vol.6, pp.111-122, 2002. ,
Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III, J. Pediatr. Surg, vol.31, pp.191-196, 1996. ,
Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG, Ann. Surg. Oncol, vol.19, pp.2981-2991, 2012. ,
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET), 2013. ,
, Ann. Oncol, vol.24, pp.1685-1691
Prospective evaluation of quality of surgery in soft tissue sarcoma, Eur. J. Surg. Oncol, vol.32, pp.1242-1248, 2006. ,
Adhesion to clinical practices guidelines (CPGs) and role on survival for soft tissue sarcoma patients, 2012. ,
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas, Ann Oncol, vol.15, pp.307-315, 2004. ,
Common musculoskeletal tumors of childhood and adolescence, N. Engl. J. Med, vol.341, pp.342-352, 1999. ,
Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on intergroup rhabdomyosarcoma study group (IRSG) protocols II-IV, 1978-1997: report from the children's oncology group, Pediatr. Blood Cancer, vol.51, pp.17-22, 2008. ,
, Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV, vol.35, pp.317-321, 1991.
Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group, J. Clin. Oncol, vol.29, pp.1304-1311, 2011. ,
Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups, J. Clin. Oncol, vol.26, pp.2384-2389, 2008. ,
,
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma-a report from the Intergroup Rhabdomyosarcoma Study IV, J. Clin. Oncol, vol.21, pp.78-84, 2003. ,
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas, J. Clin. Oncol, vol.31, pp.608-615, 2013. ,
Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation, J. Clin. Oncol, vol.6, pp.67-75, 1988. ,
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study, Cancer, vol.76, pp.1073-1085, 1995. ,
Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group, J. Clin. Oncol, vol.24, pp.3844-3851, 2006. ,
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults, J. Clin. Oncol, vol.27, pp.1446-1455, 2009. ,
Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group, Pediatr. Blood Cancer, vol.42, pp.64-73, 2004. ,
Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies, Pediatr. Blood Cancer, vol.59, pp.5-10, 2012. ,
Risk stratification of rhabdomyosarcoma, Am Soc Clin Oncol Educ Book, vol.2013, pp.415-419, 2013. ,
Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group, J. Clin. Oncol, vol.29, pp.1312-1318, 2011. ,
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study, J. Clin. Oncol, vol.30, pp.2457-2465, 2012. ,
Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease, Eur. J. Cancer, vol.44, pp.427-431, 2008. ,
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer, Cochrane Database Syst. Rev. CD006647, 2009. ,